Steven H. Stein - 18 Jan 2024 Form 4 Insider Report for INCYTE CORP (INCY)

Role
EVP & Chief Medical Officer
Signature
/s/ Elizabeth Feeney, Attorney-In-Fact
Issuer symbol
INCY
Transactions as of
18 Jan 2024
Transactions value $
$0
Form type
4
Date filed
22 Jan 2024, 13:02
Previous filing
05 Jan 2024
Next filing
16 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INCY Employee Stock Option (right to buy) Award $0 +30.6K $0.00 30.6K 18 Jan 2024 Common Stock 30.6K $61.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Beginning January 18, 2024, options become exercisable in 37 installments, with the first 25% vesting on July 14, 2024 and the remainder vesting monthly over three years.